While nausea, vomiting, and diarrhea are class effects, their severity and clinical impact vary substantially across drugs
GLP-1 drugs are now widely known for their effectiveness in weight loss
The Triple-Agonist Obesity Drug Explained Tool: reconstitution calculator Sources Jastreboff AM, Kaplan LM, Frias JP, et al
Chronic inflammation can lead to ongoing pain and damage to tissues, such as in conditions like arthritis or ankylosing spondylitis, which often cause back pain
GobyMeds and most GLP-1 telehealth platforms are primarily designed for patients with obesity (BMI 30 or above) or those with at least one weight-related comorbidity at a BMI of 27 or above
While most widely recognized in depression, it occurs across multiple conditions and deserves careful attention in clinical practice